| Efficacy and Safety Study of Romiplostim N01 for Cancer Treatment-induced Thrombocytopenia (CTIT) in the Treatment of Leukemia | Cancer Treatment-induced Thrombocytopenia (CTIT) | Recruiting | Phase 2 | 2026-08-24 | | NCT06898983 |
|---|
| Effect of Stem Cell Infusion Time on aGVHD in Patients With Nonmalignant Hematologic Diseases | Acute Graft-versus-host Disease | Recruiting | Phase 3 | 2026-08-24 | | NCT06294691 |
|---|
| Effect of Stem Cell Infusion Time on aGVHD in Patients With Hematological Malignancies | Acute Graft-versus-host Disease | Active, not recruiting | Phase 3 | 2025-12-31 | | NCT06294678 |
|---|
| Avatrombopag for Platelet Recovery Post-UCBT in Patients With Bone Marrow Failure Disease | Platelet Recovery After Umbilical Cord Blood Transplantation | Recruiting | Not stated | 2024-12-31 | | NCT05823376 |
|---|
| The Safety and Efficacy of Coenzyme I for Injection in Promoting Hematopoietic Recovery of Patients After sUCBT | Hematopoietic Recovery | Recruiting | Phase 1 | 2024-12-18 | | NCT06558253 |
|---|
| The Efficacy and Safety of Desensitation Regimen for Patients With High Titers of Anti-HLA Antibodies Prior to Allo-HSCT | High Titers of Anti-HLA Antibody (MFI ≥5000) | Recruiting | Phase 2 | 2024-12-18 | | NCT06362967 |
|---|
| Romiplostim N01 for Platelet Recovery in Adult Hematologic Malignancies Patients Undergoing UCBT | Platelet Recovery After Umbilical Cord Blood Transplantation | Recruiting | Phase 2 | 2024-11-18 | | NCT06693791 |
|---|